Cesario V Borlongan Selected Research

hippocampal cholinergic neurostimulating peptide

1/2012	Suppression of astrocyte lineage in adult hippocampal progenitor cells expressing hippocampal cholinergic neurostimulating Peptide precursor in an in vivo ischemic model.
2/2009	Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.
7/2007	Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cesario V Borlongan Research Topics

Disease

41	Stroke (Strokes) 01/2022 - 01/2002
20	Inflammation (Inflammations) 01/2022 - 07/2006
16	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2002
15	Ischemic Stroke 01/2022 - 08/2004
9	Infarction (Infarctions) 01/2022 - 01/2002
7	Wounds and Injuries (Trauma) 01/2012 - 07/2004
6	Central Nervous System Diseases (CNS Diseases) 01/2022 - 08/2004
6	Nervous System Diseases (Neurological Disorders) 01/2022 - 06/2009
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 06/2004
6	Ischemia 01/2016 - 09/2004
6	Brain Ischemia (Cerebral Ischemia) 01/2014 - 01/2002
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 07/2015
4	Disease Progression 01/2022 - 05/2011
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2022 - 01/2018
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2016
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2021
3	Neuroinflammatory Diseases 01/2021 - 01/2016
3	Epilepsy (Aura) 02/2017 - 11/2013
3	Huntington Disease (Huntington's Disease) 01/2008 - 11/2002
3	Brain Injuries (Brain Injury) 07/2006 - 01/2002
2	Hypoxia (Hypoxemia) 01/2022 - 04/2019
2	Myocardial Infarction 01/2022 - 01/2016
2	Neoplasms (Cancer) 01/2022 - 01/2017
2	Peripheral Nerve Injuries 12/2016 - 01/2012
2	Edema (Dropsy) 09/2014 - 08/2012
2	Seizures (Absence Seizure) 11/2013 - 11/2009
2	Alzheimer Disease (Alzheimer's Disease) 02/2009 - 03/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2009 - 07/2004
2	Cerebral Infarction 01/2006 - 03/2005
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Hypersplenism (Anemia, Splenic) 01/2022
1	Anemia 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Purpura 01/2020
1	Cerebral Hemorrhage 01/2020

Drug/Important Bio-Agent (IBA)

9	Neuroprotective AgentsIBA 01/2021 - 01/2002
5	Therapeutic UsesIBA 01/2022 - 11/2009
5	Peptides (Polypeptides)IBA 01/2021 - 01/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 07/2004
4	Oxygen (Dioxygen)IBA 01/2022 - 01/2018
4	CytokinesIBA 01/2021 - 01/2016
4	Nerve Growth Factors (Neurotrophins)IBA 01/2008 - 06/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	ST 1435IBA 01/2022 - 01/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2002
3	Evans Blue (Blue, Evans)FDA Link 09/2014 - 06/2004
3	hippocampal cholinergic neurostimulating peptideIBA 01/2012 - 07/2007
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2006 - 01/2002
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2005 - 11/2002
2	Mevalonic Acid (Mevalonate)IBA 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2022
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2005
2	Long Noncoding RNAIBA 01/2020 - 07/2018
2	Progestins (Progestagens)IBA 01/2019 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 08/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2016
2	Alprostadil (Muse)FDA LinkGeneric 01/2017 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 07/2015 - 07/2006
2	Oxidopamine (6 Hydroxydopamine)IBA 05/2011 - 01/2005
2	Quinolinic AcidIBA 01/2008 - 11/2007
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2005 - 08/2004
2	Methylprednisolone FDA LinkGeneric 02/2005 - 08/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2005 - 06/2004
1	Lipoproteins (Lipoprotein)IBA 07/2022
1	EnzymesIBA 01/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Sirtuin 3IBA 01/2022
1	ferric oxide (iron oxide)IBA 01/2022
1	CateninsIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	CalciumIBA 12/2021
1	erucylphosphocholineIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	ElementsIBA 01/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2020

Therapy/Procedure

33	Therapeutics 01/2022 - 07/2004
27	Transplantation 01/2021 - 01/2002
8	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2009
4	Deep Brain Stimulation 01/2021 - 01/2011
4	Cell Transplantation 02/2017 - 07/2004
3	Stem Cell Transplantation 01/2021 - 01/2015
3	Injections 01/2008 - 03/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Catheters 10/2021
1	Vagus Nerve Stimulation 01/2021